This Amendment No. 1 (this “Amendment No. 1”) amends and
supplements the Solicitation/Recommendation Statement on Schedule 14D-9 (as further amended or supplemented from time to time, the “Schedule 14D-9”)
previously filed by Potbelly Corporation, a Delaware corporation (the “Company”), with the Securities and Exchange Commission (the “SEC”) on September 23, 2025.
The Schedule 14D-9 relates to the tender offer by Hero Sub Inc., a Delaware corporation
(“Purchaser”) and a wholly owned subsidiary of RaceTrac, Inc., a Georgia corporation (“Parent” or “RaceTrac”), to purchase, subject to certain conditions, any and all of the outstanding Shares
at a price of $17.12 per Share, without interest (the “Offer Price”), net to the seller in cash, less any applicable withholding taxes, upon the terms and subject to the conditions set forth in the Offer to Purchase, dated
September 23, 2025 (as it may be amended or supplemented from time to time, the “Offer to Purchase”), and in the related Letter of Transmittal (as it may be amended or supplemented from time to time, the “Letter of
Transmittal” and, together with the Offer to Purchase, the “Offer”). The Offer is described in the Tender Offer Statement on Schedule TO filed with the SEC on September 23, 2025, by Purchaser and Parent (together
with any amendments and supplements thereto). The Offer is being made pursuant to an Agreement and Plan of Merger, dated as of September 9, 2025 (the “Merger Agreement”), by and among the Company, Parent and Purchaser. The
Merger Agreement provides, among other things, that following the consummation of the Offer and subject to the satisfaction or waiver of the applicable conditions set forth in the Merger Agreement, including the Minimum Condition, Purchaser will be
merged with and into the Company, with the Company surviving as a wholly owned subsidiary of Parent.
Capitalized terms used but not otherwise defined in
this Amendment No. 1 shall have the meanings ascribed to such terms in the Schedule 14D-9. The information in the Schedule 14D-9 is incorporated into this Amendment
No. 1 by reference to all applicable items in the Schedule 14D-9, except that such information is hereby amended and supplemented to the extent specifically provided herein. Except as otherwise set forth
in this Amendment, the information set forth in the Schedule 14D-9 remains unchanged and is incorporated herein by reference to the extent relevant to the items in this Amendment.
Explanatory Note:
As described further below, in
connection with the Offer and the Merger Agreement, two complaints have been filed as individual actions by purported stockholders of the Company in the Supreme Court of the State of New York, County of New York, alleging, among other things, that
the defendants (the Company and the Board) omitted and/or misrepresented certain material facts relating to the transaction contemplated by the Merger Agreement in the Schedule 14D-9 filed by the Company on
September 23, 2025. Certain demand letters have also been sent to the Company by purported stockholders making similar allegations. The Company believes that the allegations in such complaints and demand letters are without merit. The Company
believes that no supplemental disclosure is required under applicable laws and that the Schedule 14D-9, as originally filed on September 23, 2025, disclosed all material information required to
be disclosed therein. However, to avoid the risk that lawsuits may delay or otherwise adversely affect the Transactions, and to minimize the expense of defending such actions, the Company wishes to make voluntarily certain supplemental disclosures
related to the Transactions for the purposes of mooting the allegations in any complaints related to the Transactions, all of which are set forth below and should be read in conjunction with the
Schedule 14D-9 in its entirety. Nothing in these supplemental disclosures shall be deemed an admission of the legal necessity or materiality under applicable laws of any of the disclosures set forth
herein.
Item 3. Past Contacts, Transactions, Negotiations and Agreements.
Item 3 of the Schedule 14D-9 is hereby amended and supplemented as follows:
| |
1. |
By adding the below paragraph after the first full paragraph under the section titled “Conflicts of
Interest” on page 4 as follows: |
Additionally, other than discussions or negotiations with respect to
employment-related or compensation-related matters already disclosed in this Schedule 14D-9, prior to the execution of the Merger Agreement, there were no discussions or negotiations that occurred between
Parent, Purchaser or their respective affiliates and any of the Company’s management, executive officers or directors with respect to post-closing employment, compensation or benefits.